Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Overview

The project titled "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to address the challenges faced in delivering effective treatments for cancer by developing innovative drug delivery systems. Cancer remains a leading cause of mortality worldwide, and current treatment options often come with severe side effects and limited efficacy due to the inability to specifically target cancer cells. Therefore, the development of novel drug delivery systems that can target cancer cells while minimizing damage to healthy tissues is crucial in improving cancer treatment outcomes. The research will focus on exploring and developing various drug delivery systems, such as nanoparticles, liposomes, and micelles, that can enhance the targeted delivery of anti-cancer drugs to tumor sites. These systems offer advantages such as improved drug solubility, stability, prolonged circulation time, and the ability to target specific receptors on cancer cells. By encapsulating anti-cancer drugs within these delivery systems, it is possible to enhance their accumulation at the tumor site, improve their therapeutic efficacy, and reduce systemic toxicity. The project will also investigate the potential of incorporating targeting ligands, such as antibodies or peptides, onto the surface of drug delivery systems to further enhance their specificity for cancer cells. These targeting ligands can recognize and bind to specific receptors overexpressed on cancer cells, allowing for precise delivery of therapeutic agents to tumors while sparing healthy tissues. Furthermore, the research will explore the use of stimuli-responsive drug delivery systems that can release anti-cancer drugs in response to specific triggers present in the tumor microenvironment, such as pH, enzymes, or temperature. This approach can further enhance the selectivity and efficacy of drug delivery to cancer cells, providing a more personalized and effective treatment strategy. Overall, the development of novel drug delivery systems for targeted cancer therapy holds great promise in revolutionizing cancer treatment by improving drug efficacy, reducing side effects, and ultimately enhancing patient outcomes. Through this research, we aim to contribute to the advancement of cancer therapeutics and pave the way for more effective and personalized treatment options for cancer patients.